Cargando…
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na(+), K(+))-, Mg(2+)-ATPase activities, antioxidant status, and learning performance of aged rats
We investigated the effects of rivastigmine (a cholinesterase inhibitor) and selegiline ((-)deprenyl, an irreversible inhibitor of monoamineoxidase-B), alone and in combination, on brain acetylcholinesterase (AChE), (Na(+), K(+))-, Mg(2+)-ATPase activities, total antioxidant status (TAS), and learni...
Autores principales: | Carageorgiou, Haris, Sideris, Antonios C, Messari, Ioanna, Liakou, Chrissoula I, Tsakiris, Stylianos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536534/ https://www.ncbi.nlm.nih.gov/pubmed/19043511 |
Ejemplares similares
-
Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
por: Bezerra da Silva, Cristiane, et al.
Publicado: (2016) -
Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019) -
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah, Nagaendran, et al.
Publicado: (2017) -
The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications
por: Eldufani, Jabril, et al.
Publicado: (2019) -
Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)